Derma Sciences (DSCI) Announces Common Offering

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that it intends to offer shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Piper Jaffray & Co. is acting as the sole book-running manager for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Vincerx Pharma (VINC) Announces Proposed Share and Warrant Offering
• Pulse Biosciences (PLSE) Files for 6M Rights Offering
• MAIA Biotechnology (MAIA) Announces $1.00 Million Private Placement